<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39365725</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2168-2208</ISSN><JournalIssue CitedMedium="Internet"><Volume>PP</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>IEEE journal of biomedical and health informatics</Title><ISOAbbreviation>IEEE J Biomed Health Inform</ISOAbbreviation></Journal><ArticleTitle>Acoustic COVID-19 Detection Using Multiple Instance Learning.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1109/JBHI.2024.3474975</ELocationID><Abstract><AbstractText>In the COVID-19 pandemic, a rigorous testing scheme was crucial. However, tests can be time-consuming and expensive. A machine learning-based diagnostic tool for audio recordings could enable widespread testing at low costs. In order to achieve comparability between such algorithms, the DiCOVA challenge was created. It is based on the Coswara dataset offering the recording categories cough, speech, breath and vowel phonation. Recording durations vary greatly, ranging from one second to over a minute. A base model is pre-trained on random, short time intervals. Subsequently, a Multiple Instance Learning (MIL) model based on self-attention is incorporated to make collective predictions for multiple time segments within each audio recording, taking advantage of longer durations. In order to compete in the fusion category of the DiCOVA challenge, we utilize a linear regression approach among other fusion methods to combine predictions from the most successful models associated with each sound modality. The application of the MIL approach significantly improves generalizability, leading to an AUC ROC score of 86.6% in the fusion category. By incorporating previously unused data, including the sound modality 'sustained vowel phonation' and patient metadata, we were able to significantly improve our previous results reaching a score of 92.2%.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reiter</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Franz</LastName><ForeName>Pernkopf</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>IEEE J Biomed Health Inform</MedlineTA><NlmUniqueID>101604520</NlmUniqueID><ISSNLinking>2168-2194</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39365725</ArticleId><ArticleId IdType="doi">10.1109/JBHI.2024.3474975</ArticleId></ArticleIdList></PubmedData></PubmedArticle>